Clincosm LogoSign in Get a demo

A Novel Virtual Reality Task in Parkinson's Disease

Sponsor
New York Institute of Technology (Other)
Overall Status
Recruiting
CT.gov ID
NCT05859308
Collaborator
(none)
6
Enrollment
1
Location
2
Arms
12
Anticipated Duration (Months)
0.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to compare experiences and effects of a virtual reality physical program to an in-person Rock Steady Boxing Program. People with Parkinson's disease, age 18 and up, who participate in Rock Steady Boxing weekly may join this study.

Condition or Disease Intervention/Treatment Phase
  • Other: Virtual Reality Pixel Plucker
  • Other: Rock Steady Boxing
 N/A

Detailed Description

If you agree to be in this study, we will ask you to do the following things:

Provide basic information about yourself, complete tests of thinking on the computer and in person, participate in your regular Rock Steady boxing, and for three weeks replace your Rock Steady Boxing with a virtual reality game done with a headset. You will work independently with a study team member.

  • Visit 1 or Visit 1 and 2 if split up: Beginning Measures/Demographics, Parkinson's disease symptoms, Cognition (about 45 minutes), VR training (30 minutes) or Regular Rock Steady Boxing (1 hour)

  • Visit 2-5: Virtual Reality training (30 minutes or Regular Rock Steady Boxing (1 hour)

  • Visit 6: Virtual Reality training (30 minutes) or Regular Rock Steady Boxing (1 hour), Cognitive measures (about 20 minutes)

  • Visit 7: Cognitive measures (about 20 minutes), Virtual Reality training (30 minutes) or Regular Rock Steady Boxing (1 hour); Intrinsic Motivation Inventory (5 minutes)

  • Visit 8-11: Virtual Reality training (30 minutes) or Regular Rock Steady Boxing (1 hour)

  • Visit 12 or Visit 13 if baseline was split up: Virtual Reality training (30 minutes) or Regular Rock Steady Boxing (1 hour), Cognitive Measures (20 minutes), Intrinsic Motivation Inventory (5 minutes), End of Study Survey (5-10 minutes)

Study Design

Study Type:
Interventional
Anticipated Enrollment :
6 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Crossover Pilot Study of a Novel Virtual Reality Task in Parkinson's Disease Compared to a Group In-Person Rock Steady Boxing Program; Task Performance, Cognitive Outcomes, Perceptions, and Comparisons
Anticipated Study Start Date :
May 15, 2023
Anticipated Primary Completion Date :
May 15, 2024
Anticipated Study Completion Date :
May 15, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Boxing

Rock Steady Boxing

Other: Rock Steady Boxing
An in-person boxing class designed for individuals with Parkinson's disease.
Experimental: Virtual Reality Pixel Plucker

30 minutes of VR engagement

Other: Virtual Reality Pixel Plucker
A virtual reality task where participants wear the Virtual Reality headset and respond to targets.

Outcome Measures

Primary Outcome Measures

  1. Stroop Test, Inquisit Millisecond [through study completion, an average of one year]

    measure of executive function

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:

  • Diagnosed with Parkinson's disease

  • Age 18+ years

  • Currently involved in rock steady boxing

  • Willing to participate 2-3 days/week

Exclusion criteria:

  • Known history of movement-induced vertigo

  • Other cognitive or movement disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 NYIT Old Westbury New York United States 11568

Sponsors and Collaborators

  • New York Institute of Technology

Investigators

  • Principal Investigator: Amber Sousa, PhD, NYIT

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amber Sousa, Assistant Professor, Neuropsychologist, New York Institute of Technology
ClinicalTrials.gov Identifier:
NCT05859308
Other Study ID Numbers:
  • BHS-1843
First Posted:
May 15, 2023
Last Update Posted:
May 16, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Parkinson Disease

Study Results

No Results Posted as of May 16, 2023